Getting an Accurate Diagnosis: Imaging and Criteria
At a Glance
ADPKD is primarily diagnosed using ultrasound based on the Pei-Unified criteria, which considers age and cyst count. MRIs offer more precise cyst detection and measure Total Kidney Volume (TKV) to predict disease progression. Genetic testing is used for atypical cases or family planning.
Diagnosing ADPKD is not just about finding cysts; it is about looking at those cysts in the context of your age and family history. Because it is common for healthy people to develop a few “simple” kidney cysts as they age, doctors use specific, evidence-based rules to ensure an accurate diagnosis [1][2].
The Gold Standard: Ultrasound Criteria
For most people, an ultrasound is the first tool used for diagnosis because it is safe, widely available, and does not use radiation. Doctors use the Pei-Unified criteria to determine if the number of cysts is high enough to confirm ADPKD in someone with a family history of the disease [2].
Because ADPKD is progressive, the “cutoff” number for a diagnosis changes as you get older [2]:
- Ages 15–39: At least 3 cysts total (in one or both kidneys combined) [2].
- Ages 40–59: At least 2 cysts in each kidney [2].
- Ages 60+: At least 4 cysts in each kidney [2].
If you do not have a known family history, the bar for diagnosis is higher—usually 10 or more cysts in each kidney are needed to distinguish ADPKD from normal aging [1][3].
When MRI is the Better Choice
While ultrasound is great for a basic diagnosis, an MRI (Magnetic Resonance Imaging) is much more sensitive. It can detect tiny cysts that an ultrasound might miss, which is especially important for younger patients (under age 40) or those with the slower-progressing PKD2 gene [4][2].
More importantly, MRI is the preferred tool for measuring Total Kidney Volume (TKV) [5]. TKV is not just a measurement of size; it is a “biomarker” that helps your doctor predict how quickly your kidney function might decline in the future [6][7]. This measurement helps place you into a Mayo Imaging Classification (risk categories 1A through 1E), which determines if you are a candidate for certain treatments [6][8].
The Role of Genetic Testing
In about 10-15% of cases, imaging alone isn’t enough [9]. Your doctor might recommend genetic testing if:
- You have no family history of the disease [9].
- Your imaging results are “atypical” (for example, cysts are only in one kidney or are very unevenly distributed) [9][10].
- You are a young person (under 30) who wants to donate a kidney and needs to be 100% sure you don’t carry the gene [11][9].
- You are planning a family and want to discuss options for preventing transmission [12][13].
Completeness Checklist: Your Imaging Report
When you receive your radiology report, check for these specific details. If they are missing, you may want to ask your nephrologist for a more detailed review:
- [ ] Total Kidney Volume (TKV): Ideally height-adjusted (HtTKV).
- [ ] Kidney Dimensions: Length, width, and thickness of each kidney [14].
- [ ] Cyst Description: Are the cysts “simple” or “complex” (containing blood or protein)?
- [ ] Extrarenal Findings: Does the report mention cysts in the liver or pancreas [15]?
- [ ] Complications: Any mention of kidney stones, calcifications, or unusual blood vessel patterns [14]?
- [ ] Atypical Features: Does the imaging follow a “typical” pattern (Class 1) or an “atypical” pattern (Class 2)? (Atypical patterns often grow more slowly) [16].
Common questions in this guide
How many cysts do you need to be diagnosed with ADPKD?
Why might my doctor order an MRI instead of an ultrasound for ADPKD?
Is genetic testing required to diagnose ADPKD?
What is Total Kidney Volume (TKV) and why does it matter?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my age and the number of cysts seen on my ultrasound, do I meet the Pei-Unified criteria for a definitive diagnosis?
- 2.What was my Height-Adjusted Total Kidney Volume (HtTKV), and which Mayo Clinic risk class (1A-1E) does that place me in?
- 3.If we only used ultrasound, is there a chance we missed smaller cysts that an MRI might have detected?
- 4.Given my family history (or lack thereof), would genetic testing help clarify my diagnosis or predict how fast my disease might progress?
- 5.Were there any 'complex' cysts, stones, or signs of infection noted in the 'extra findings' section of my report?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
Fujimaru T, Mori T, Sekine A, et al.
Clinical genetics 2018; (94(1)):125-131 doi:10.1111/cge.13249.
PMID: 29520754 - 2
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review.
Harnan S, Gittus M, Falzon L, et al.
Clinical kidney journal 2025; (18(7)):sfaf187 doi:10.1093/ckj/sfaf187.
PMID: 40697969 - 3
Clinical significance of incidentally discovered renal cysts in pediatric patients.
Botwin A, Phewplung T, Wu K, et al.
Abdominal radiology (New York) 2019; (44(8)):2835-2840 doi:10.1007/s00261-019-02017-z.
PMID: 30972430 - 4
MRI in autosomal dominant polycystic kidney disease.
Zhang W, Blumenfeld JD, Prince MR
Journal of magnetic resonance imaging : JMRI 2019; (50(1)):41-51 doi:10.1002/jmri.26627.
PMID: 30637853 - 5
A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ, Doshi T, Metherall P, et al.
European radiology 2019; (29(8)):4188-4197 doi:10.1007/s00330-018-5918-9.
PMID: 30666443 - 6
Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S, Dev H, Blumenfeld JD, et al.
Journal of magnetic resonance imaging : JMRI 2021; (53(2)):564-576 doi:10.1002/jmri.27360.
PMID: 32969110 - 7
Burden of Proof for Tolvaptan in ADPKD: Did REPRISE Provide the Answer?
Mustafa RA, Yu ASL
Clinical journal of the American Society of Nephrology : CJASN 2018; (13(7)):1107-1109 doi:10.2215/CJN.00190118.
PMID: 29653956 - 8
Intrafamilial Variability of ADPKD.
Lanktree MB, Guiard E, Li W, et al.
Kidney international reports 2019; (4(7)):995-1003 doi:10.1016/j.ekir.2019.04.018.
PMID: 31317121 - 9
Many lessons still to learn about autosomal dominant polycystic kidney disease.
Orr S, Sayer JA
Journal of rare diseases (Berlin, Germany) 2023; (2(1)):13 doi:10.1007/s44162-023-00017-8.
PMID: 37664187 - 10
Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients.
Suzuki Y, Katayama K, Saiki R, et al.
Genes 2023; (14(2)) doi:10.3390/genes14020443.
PMID: 36833371 - 11
KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetics and Genetic Counseling.
Patel C, Tchan M, Savige J, et al.
Seminars in nephrology 2015; (35(6)):550-556.e1.
PMID: 26718158 - 12
Overview of ADPKD in Pregnancy.
Campbell RE, Edelstein CL, Chonchol M
Kidney international reports 2025; (10(4)):1011-1019 doi:10.1016/j.ekir.2024.12.035.
PMID: 40303224 - 13
Birth of two healthy girls following preimplantation genetic diagnosis and gestational surrogacy in a rapidly progressive autosomal dominant polycystic kidney disease case using tolvaptan.
Peces R, Mena R, Peces C, et al.
Clinical kidney journal 2021; (14(8)):1987-1989 doi:10.1093/ckj/sfab082.
PMID: 34345424 - 14
Reporting ADPK Disease Phenotypes on Abdominal Scans.
Hu Z, Lane EG, Lo GC, et al.
Kidney international reports 2025; (10(9)):2967-2976 doi:10.1016/j.ekir.2025.06.046.
PMID: 40980645 - 15
Predictors of autosomal dominant polycystic kidney disease progression: a Brazilian single-center cohort.
Nishimoto IH, Santos AG, Bianchini JM, et al.
Jornal brasileiro de nefrologia 2024; (46(3)):e20230040 doi:10.1590/2175-8239-JBN-2023-0040en.
PMID: 38935976 - 16
Atypical Polycystic Kidney Disease as defined by Imaging.
Iliuta IA, Win AZ, Lanktree MB, et al.
Scientific reports 2023; (13(1)):2952 doi:10.1038/s41598-022-24104-w.
PMID: 36807559
This page explains ADPKD diagnostic imaging and criteria for educational purposes only. Always consult your nephrologist or medical team for an accurate diagnosis and interpretation of your scan results.
Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.